-
Stable pharmaceutical composition for treating neurogenic detrusor overactivity, comprises mirabegron or its salt and sodium polystyrene sulfonate, where pharmaceutical composition does not contain magnesium stearate and/or calcium stearate
2023-10-11
-
Pharmaceutical composition used for treating thromboembolic disorders, comprises rivaroxaban, mannitol, anhydrous citric acid, hypromellose, sodium benzoate, combination of xanthan gum and mixture of microcrystalline cellulose and carboxymethylcellulose sodium, sucralose, flavoring agent, excipients
2023-10-04
